Cited by 17Liver Diseases and ImmunityLiver Disease and TransplantationPediatric Hepatobiliary Diseases and Treatments

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Survival following the development of ascites and/or peripheral oedema in primary biliary cirrhosis: A staged prognostic model

Chan, Chun-Wing, Carpenter, James R., Rigamonti, Cristina, Gunsar, Fulya, Burroughs, Andrew K.·2005·Scandinavian Journal of Gastroenterology

Abstract

OBJECTIVE: Current prognostic models in primary biliary cirrhosis (PBC) have low precision, partly due to the restricted inclusion criteria of some cohorts used for modelling but also because of the prolonged natural course of the disease. It is hypothesized that better precision could be achieved with a staged model, using ascites or peripheral oedema as a new starting-point for prediction. MATERIAL AND METHODS: The study was based on an established database of 289 consecutive patients, followed between 1977 and 1998. Stepwise Cox regression was used to construct a staged model based on 143 patients who first developed ascites (n=111) or peripheral oedema (n=32) at entry or during subsequent follow-up. The model was compared with published models using graphical methods and receiver operating characteristics (ROCs). RESULTS: Mean time from clinical diagnosis of ascites or peripheral oedema to death was 3.1 years. The following variables had independent prognostic significance: log10(bilirubin) (p<0.001), albumin (p<0.001), age (p<0.001) and history of encephalopathy (p<0.001). Goodness of fit showed that the survival probabilities predicted by the Ascites Stage Model fitted well with the observed data. The Ascites Stage Model (ROC 0.8324 (SE 0.0348)) was a better predictor of survival than the Mayo long-term model (ROC 0.7833 (SE 0.0397)), the Mayo Repeated Patient Visits Model (ROC 0.7779 (SE 0.0399)) and the Royal Free PBC Prognostic Model (ROC 0.7785 (SE 0.0396)). CONCLUSIONS: The Ascites Stage Model gives a better survival estimate for PBC patients once they have developed ascites or peripheral oedema compared with the current models, and demonstrates an advantage of staged models in diseases with a prolonged natural history.

Overview

Integrity signals

Registry

Crossref · 10.1080/00365520510023215

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 4

  1. Gluud C, The Cochrane Library
  2. Salerno F, 1993, Am J Gastroenterol, 88, 514
  3. Cleves M, 1999, Stata Tech Bull, 52, sg120
  4. Goudie BM, 1989, Am J Gastroenterol, 84, 713

Cited by

Sorted by citations

See all 17

Metadata

Authors
Chan, C.-W., Carpenter, J. R., Rigamonti, C., Gunsar, F., & Burroughs, A. K.
Affiliations
  • The Royal Free Hospital (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Royal Free London NHS Foundation Trust (GB)
Corresponding author
Burroughs, Andrew K.
Venue
Scandinavian Journal of Gastroenterology
Published
2005-01
Volume
40
Issue
9
Pages
1081-1089
ISSN
  • 0036-5521 (ISSN-L)
  • 1502-7708
OpenAlex
W2148674881
Cited by
17
References
21
Citations by year
2026: 1 · 2020: 1 · 2018: 4 · 2017: 1 · 2013: 2 · 2012: 1
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Scandinavian Journal of Gastroenterology (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
Economic and Social Research Council
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
primary biliary cirrhosis, ascites, peripheral edema, survival prediction, prognostic model, bilirubin, serum albumin, encephalopathy
MeSH terms
Ascites, Edema, Female, Follow-Up Studies, Humans, Liver Cirrhosis, Biliary, Male, Middle Aged, Prognosis, Retrospective Studies, Severity of Illness Index, Time Factors, Survival Rate, Proportional Hazards Models, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review